Evidence map›Paper›PMID 40895645›Full record

ArticleNature reviews. Materials2019

Ingestible Electronics for Diagnostics and Therapy.

Christoph Steiger, Alex Abramson, Phillip Nadeau, Anantha P Chandrakasan, Robert Langer, Giovanni Traverso

Abstract read
In one paragraph

Article in Nature reviews. Materials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. An Edible HAdvanced healthcare materials · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Physical Intelligence in Small-Scale Robots and Machines.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christoph SteigerKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge MA, USA.
Alex AbramsonKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge MA, USA.
Phillip NadeauMicrosystem Technology Laboratories, Massachusetts Institute of Technology, Cambridge MA, USA.
Anantha P ChandrakasanMicrosystem Technology Laboratories, Massachusetts Institute of Technology, Cambridge MA, USA.
Robert LangerKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge MA, USA.
Giovanni TraversoKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge MA, USA.

Funding

CONTROLLED RELEASE OF MACROMOLECULESR01EB000244 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LANGER, ROBERT SAMUEL, TRAVERSO, CARLO GIOVANNI · 2002 to 2021
$6.1M
Controlled Release of MacromoleculesR37EB000244 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LANGER, ROBERT SAMUEL · 2008 to 2017
$3.9M
NIBIB NIH HHS R01 EB000244NIBIB NIH HHS R37 EB000244
6 · The paper itself

Abstract

The gastrointestinal (GI) tract offers the opportunity to detect physiological and pathophysiological signals from the human body. Ingestible electronics can gain close proximity to major organs through the GI tract and therefore, can serve as clinical tools for diagnostics and therapy. In this Review, we summarize physiologic and anatomic characteristics of the GI tract, which present both challenges and opportunities for the development of ingestible devices. We describe recent breakthroughs in material science, electrical engineering, and data science that have permitted exploration of technologies for both sensing and therapy via the GI tract. Novel sensing opportunities include electrochemical, electromagnetic, optical, and acoustic protocols, with capacity to sense luminal or extra-luminal analytes in the GI tract. We review novel therapeutic interventions such as anatomic targeting of drug delivery, enhanced drug delivery including the delivery of macromolecules and potentially the delivery of electrical signals as the therapy. Finally, we investigate major challenges associated with ingestible electronics, including safety, communication, powering, steering and tissue interactions. Ingestible electronics are an exciting arena of scientific innovation and they may pave the way for a novel area in medicine, enabling patients to receive remote, electronically-assisted health care.

Identifiers

PMID40895645
PMCPMC12393167

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.